创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: The main advantages of in vitro cell-killing experimental platforms

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-08 14:52
  • Views:

(Summary description)In the vast ocean of biomedical research, cell killing experimental platform occupies an important position. As an advanced experimental tool, as well as its unique technical features and significant advantages, the in vitro cell-killing experimental platform of InnoModels Biotechnology provides researchers with a more accurate and efficient means of research. In this paper, we will introduce the main advantages of InnoModels Biotechnology biocidal experimental platform and discuss its application prospects in biomedical research.

InnoModels Biotechnology: The main advantages of in vitro cell-killing experimental platforms

(Summary description)In the vast ocean of biomedical research, cell killing experimental platform occupies an important position. As an advanced experimental tool, as well as its unique technical features and significant advantages, the in vitro cell-killing experimental platform of InnoModels Biotechnology provides researchers with a more accurate and efficient means of research. In this paper, we will introduce the main advantages of InnoModels Biotechnology biocidal experimental platform and discuss its application prospects in biomedical research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-08 14:52
  • Views:
Information

In the vast ocean of biomedical research, cell killing experimental platform occupies an important position. As an advanced experimental tool, as well as its unique technical features and significant advantages, the in vitro cell-killing experimental platform of InnoModels Biotechnology provides researchers with a more accurate and efficient means of research. In this paper, we will introduce the main advantages of InnoModels Biotechnology biocidal experimental platform and discuss its application prospects in biomedical research.
1、Highly simulate the in vivo environment
By simulating the physiological and pathological environments in the body, InnoModels' in vitro killing experiment platform makes the results of in vitro experiments closer to the real situation. This includes the simulation of the tumor microenvironment, the interaction between immune cells, and the metabolic process of drugs in the body. By highly simulating the in vivo environment, the platform is able to more accurately assess the cell killing effect and drug action mechanism.
2. Flexible and adjustable experimental conditions
Compared with the traditional experimental platforms, the InnoModels Biotechnology In Vitro Killing Experimental Platform has a higher degree of flexibility and adjustability. Researchers can freely adjust the experimental conditions according to their research needs, such as cell type, drug concentration, incubation time and so on. Such flexible experimental conditions enable researchers to comprehensively and systematically study the cell killing process and drug action mechanism.

 


3、Efficient experimental operation
InnoModels' in vitro cell-killing experimental platform adopts automated, high-throughput experimental operation, which greatly improves the experimental efficiency. With the automated liquid handling system, cell culture equipment and testing instruments, the platform is able to complete a large number of experiments in a short period of time, thus accelerating the research process.
4. Accurate experimental results
By introducing advanced imaging technology and data analysis methods, the platform makes the experimental results more accurate and reliable. Researchers can observe the cell killing process through a high-resolution microscope and use data analysis software to quantitatively analyze and interpret the experimental results. Such precise experimental results help researchers to better understand the cell killing mechanism and drug action mechanism.
5、Wide range of applications
InnoModels' in vitro cell-killing experimental platform has a wide range of applications in the field of biomedical research. The platform can be used to study tumor immunotherapy, antiviral drug screening, and autoimmune diseases. Through this platform, researchers can evaluate the cell killing effect of different therapeutic methods and screen potential drug candidates to provide strong support for clinical treatment.
In conclusion, with its advantages of highly simulated in vivo environment, flexible and adjustable experimental conditions, efficient experimental operation, accurate experimental results and wide range of applications, the InnoModels Biotechnology in vitro cell-killing experimental platform opens up new horizons for biomedical research. With the continuous development and improvement of the technology, it is believed that the platform will bring broader application prospects for cell therapy and drug screening.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司